www.monitoringthefuture.org/data/07data.html#2007data-cigs (accessed 2008 May 21)
Doll R, Peto R, Boreham J, et al
37 Controlled trials suggest that these agents are effective in treating tobacco dependence (Table 2), but they have a greater incidence of adverse effects and should be reserved for patients unable to quit with medications approved for smoking cessation
Ethically, clinicians should: Avoid minimizing the impacts of dependence Screen for comorbid disorders Ensure treatment goals align with client values and evidence-based practice Accurate diagnosis and careful documentation also support professional liability protection and service continuity
With free options and tools that can be customized and combined to provide the best fit for you, the Oklahoma Tobacco Helpline is a tremendous public asset to Oklahomans wanting to quit tobacco and better engage full, healthy living, said Jon Hart, Ph.D., Oklahoma Tobacco Helpline director